Abstract:Background Despite much improvement in the treatment for acute lymphoblastic leukemia (ALL), childhood ALLs with MLL -rearrangement ( MLL -r) still have inferior dismal prognosis. Thus, defining mechanisms underlying MLL -r ALL maintenance is critical for developing effective therapy. Methods GSE13159 and GSE28497 were selected via the Oncomine website. Differentially expressed genes (DEGs) between MLL -r ALLs and normal samples were identified by R software. Next, functional enrichment analysis of these DEGs were carried out by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Set Enrichment Analysis (GSEA), and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING). Then, the key hub genes and modules were identified by Weighted Gene Co-expression Network Analysis (WGCNA). Therapeutically Applicable Research to Generate Effective Treatments (TARGET) ALL (Phase I) of UCSC Xena analysis, qPCR, and Kaplan-Meier analysis were conducted for validating the expression of key hub genes from bone marrow cells of childhood ALL patients or ALL cell lines. Results A total of 1,045 DEGs were identified from GSE13159 and GSE28497. Through GO, KEGG, GSEA, and STRING analysis, we demonstrated that MLL -r ALLs were upregulating “nucleosome assembly” and “B cell receptor signal pathway” genes or proteins. WGCNA analysis found 18 gene modules using hierarchical clustering between MLL -r ALLs and normal. The Venn diagram was used to filter the 98 hub genes found in the key module with the 1,045 DEGs. We identified 18 hub genes from this process, 9 of which were found to be correlated with MLL -r status, using the UCSC Xena analysis. By using qPCR, we validated these 9 hub key genes to be upregulated in the MLL -r ALLs (RS4;11 and SEM) compared to the non- MLL -r ALL (RCH-ACV) cell lines. Three of these genes, BCL11A , GLT8D1 and NCBP2, were shown to be increased in MLL -r ALL patient bone marrows compared to the non- MLL -r ALL patient. Finally, Kaplan–Meier analysis indicated that childhood ALL patients with high BCL11A expression had significantly poor overall survival. Conclusion These findings suggest that upregulated BCL11A gene expression in childhood ALLs may lead to MLL -r ALL development and BCL11A represents a new potential therapeutic target for childhood MLL -r ALL.

B-cell ALL with SOX11 gene amplification associates with a worse outcome

Prognostic Significance of Copy Number Alterations Detected by Multi-Link Probe Amplification of Multiple Genes in Adult Acute Lymphoblastic Leukemia.

Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia

Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients' outcome

Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients

Clinical Features and Prognostic Impact of TCF3–PBX1 in Childhood Acute Lymphoblastic Leukemia: A Single-Center Retrospective Study of 837 Patients from China

Genomic imbalances analysis provides new insight into prognostic factors in adult and pediatric T-ALL

High-Throughput Sequencing Revealing BCR and TCR Repertoires as Potential Prognostic Biomarkers for Pediatric Patients with B-ALL

Association Between Plasma Somatic Copy Number Variations and Response to Immunotherapy in Patients with Programmed Death-Ligand 1-Negative Non-Small Cell Lung Cancer

High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL

Genomic signatures and prognosis of advanced stage Chinese pediatric T cell lymphoblastic lymphoma by whole exome sequencing

Spectrum and Clinical Features of Gene Mutations in Chinese Pediatric Acute Lymphoblastic Leukemia

Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure

Unraveling Copy Number Alterations in Pediatric B-Cell Acute Lymphoblastic Leukemia: Correlation with Induction Phase Remission Using MLPA

Notch1 Mutations In T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance And Implication In Multifactorial Leukemogenesis

The RAS‐signaling‐pathway‐mutation‐related prognosis in B‐cell acute lymphoblastic leukemia: A report from South China children's leukemia group

MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma

Genetic Profiling of Pediatric Patients with B-Cell Precursor Acute Lymphoblastic Leukemia

Comparative Genomic Hybridization and Transcriptome Sequencing Reveal Genes with Gain in Acute Lymphoblastic Leukemia: JUP Expression Emerges as a Survival-Related Gene

Concurrent CDX2 cis-deregulation and UBTF-ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL

BDP1 Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study